Shah Sujal bought TVRD
June 9, 2026 · Form 4 insider transaction
Shah Sujal bought 6,000 shares of Tvardi Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,000
Price
$0.00
Total value
N/A
InsiderShah Sujal
RoleDirector
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJune 9, 2026
Filing dateJune 11, 2026
Shares owned after6,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
100% of the shares underlying the option shall vest on the earlier of June 9, 2027 or the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service through such vesting date.